What is it about?
This is a cost effectiveness study to evaluate 2 commonly used first line hypertension treatments on preventing stroke and MI in Taiwan population.
Featured Image
Why is it important?
the outcome profile regarding stroke and MI, and medical cost are unique in country, thus it required a localized study to evaluate. It also summarized currently available evidence on hypertension treatment form Asian ethnic.
Read the Original
This page is a summary of: Cost-effectiveness of amlodipine compared with valsartan in preventing stroke and myocardial infarction among hypertensive patients in Taiwan, International Journal of General Medicine, May 2016, Dove Medical Press,
DOI: 10.2147/ijgm.s102095.
You can read the full text:
Contributors
The following have contributed to this page
